Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: BookHolders, Towson, MD, U.S.A.
Book
Condition: Good. [ No Hassle 30 Day Returns ][ Ships Daily ] [ Underlining/Highlighting: NONE ] [ Writing: NONE ] [ Edition: None ] slightly worn Publisher: RAND Corporation Pub Date: 2/12/2001 Binding: Paperback Pages: 140 None edition.
Published by RAND, Science and Technology Policy Institute, Drug Policy Research Center, 2000
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: Katsumi-san Co., Cambridge, MA, U.S.A.
Book First Edition
Soft cover. Condition: Very Good. 1st Edition. Volume has minor wear; tight, text clean. xxii, 119 p. [br 2].
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: Michael Lyons, HAGERSTOWN, MD, U.S.A.
Book
Condition: Good.
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: New.
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Soft Cover. Condition: new.
Published by National Book Network, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: INDOO, Avenel, NJ, U.S.A.
Book
Condition: New. Brand New.
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: As New. Unread book in perfect condition.
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Book
Condition: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp.
Published by RAND, 1999
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Book
Condition: New. Num Pages: 141 pages. BIC Classification: 1KBB; JFFH1; JPQB; KCP. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 9. Weight in Grams: 204. . 1999. Paperback. . . . .
Published by RAND, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Book
Condition: New. Num Pages: 141 pages. BIC Classification: 1KBB; JFFH1; JPQB; KCP. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 9. Weight in Grams: 204. . 1999. Paperback. . . . . Books ship from the US and Ireland.
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: As New. Unread book in perfect condition.
Published by RAND Corporation, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: New.
Published by RAND, Santa Monica, CA, 2001
ISBN 10: 0833029150ISBN 13: 9780833029157
Seller: CitiRetail, Stevenage, United Kingdom
Book
Paperback. Condition: new. Paperback. The United States spends over $16 billion a year to fight drugs, or so the Director of the Office of National Drug Control Policy (ONDCP) has certified over the past few years. What confidence is there that this budget accurately reflects federal expenditures on antidrug activities? The agencies that compile the antidrug budgets use a variety of calculation methods, some of which are problematic. Although the drug-control budget will necessarily always be a collection of estimates, it can be significantly improved, by establishing common principles to guide the calculations and by basing them on empirical data. Such steps would provide ONDCP with the ability to implement strategies and hold agencies accountable for their performance. This is essential for the ONDCP Director to be able to direct and coordinate the nation's antidrug programs and for the American people to be confident about what resources are actually being spent on antidrug activities. This text explores how anti-drug budgeting in the USA can be improved. It argues that although the drug-control budget will always be a collection of estimates, it can be significantly improved by establishing common principles to guide the calculations and by basing them on empirical data. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.